OvaScience Director Compensation Suit Settled In Del.
A proposed settlement between shareholders of fertility treatment developer OvaScience Inc. and the company's directors received court approval Thursday from a Delaware federal judge, with shareholders' attorneys receiving a $300,000 fee...To view the full article, register now.
Already a subscriber? Click here to view full article